Jyong Biotech Ltd.
MENS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001954488
No open-market purchases or sales by Jyong Biotech Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.01M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Jyong Biotech Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q4 2025
- Shares held
- 453.6K
- −237.3K (−34.3%) vs. Q4 2025
- Total value
- $974.0K
- −$1.76M (−64.3%) vs. Q4 2025
- New holders
- 4
- 6 more added
- Sold out
- 6
- 7 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MENS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.01M |
| Q1 2026 | 17 | $974.0K |
| Q4 2025 | 19 | $2.73M |
| Q3 2025 | 8 | $4.15M |
| Q2 2025 | 2 | $781.2K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Jyong Biotech Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 258,760 | $556.3K | 0.00% | −2,063−0.8% | Reduced |
| Geode Capital Management, LLC | 64,232 | $138.1K | 0.00% | −150−0.2% | Reduced |
| UBS Group AG | 37,363 | $80.3K | 0.00% | −108,285−74.3% | Reduced |
| Millennium Management LLC | 14,590 | $31.4K | 0.00% | −25,668−63.8% | Reduced |
| JustInvest LLC | 13,927 | $29.9K | 0.00% | +13,927 | New |
| China Universal Asset Management Co., Ltd. | 13,173 | $28.3K | 0.00% | +784+6.3% | Added |
| Tower Research Capital LLC (TRC) | 11,703 | $25.2K | 0.00% | +6,918+144.6% | Added |
| HRT Financial LP | 11,767 | $25.0K | 0.00% | +11,767 | New |
| Morgan Stanley | 6,301 | $13.5K | 0.00% | −21,812−77.6% | Reduced |
| Barclays PLC | 5,189 | $11.2K | 0.00% | +1,649+46.6% | Added |
| JPMorgan Chase & Co | 5,679 | $10.8K | 0.00% | −372−6.1% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 3,872 | $8.32K | 0.00% | +178+4.8% | Added |
| Citigroup Inc | 2,787 | $5.99K | 0.00% | −8,109−74.4% | Reduced |
| BNP Paribas Arbitrage, SA | 1,881 | $4.04K | 0.00% | +581+44.7% | Added |
| GF Fund Management Co. Ltd. | 1,677 | $3.61K | 0.00% | +184+12.3% | Added |
| Bell Investment Advisors, Inc | 473 | $1.02K | 0.00% | +473 | New |
| Royal Bank of Canada | 266 | $1.00K | 0.00% | +266 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −69,560−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −23,182−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −14,222−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Cornerstone Financial Management LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |